Lista de obras - Sirpa Leppä - Dominio Público Uruguay

(18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study.

artículo científico publicado en 2014

A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.

artículo científico publicado en 2007

Abstract 1169: Somatic MED12 mutations in hematological malignancies

Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells

artículo científico publicado en 2015

Adverse prognostic impact of regulatory T-cells in testicular diffuse large B-cell lymphoma

artículo científico publicado en 2020

Allogeneic Haematopoietic Stem Cell Transplantation for Patients with Cutaneous T-cell Lymphoma

scientific article published on 01 August 2016

Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma.

artículo científico publicado en 2017

Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey.

artículo científico publicado en 2004

Autologous stem cell transplantation in elderly (>60 years) patients with non-Hodgkin's lymphoma: a nation-wide analysis.

artículo científico publicado en 2006

Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.

artículo científico publicado en 2009

CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

artículo científico publicado en 2010

Clinical features and outcome of the patients with sinonasal tract diffuse large B-cell lymphoma in the pre-rituximab and rituximab eras

artículo científico publicado en 2019

Clinical findings in 25 patients with sinonasal or nasopharyngeal extramedullary plasmacytoma in a four-decade single-centre series

artículo científico publicado en 2017

Clinical findings of extranodal SNT lymphoid malignancies in a four-decade single-centre series

artículo científico publicado en 2016

Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma

article

Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study

artículo científico publicado en 2015

Deltex-1 mutations predict poor survival in diffuse large B-cell lymphoma

artículo científico publicado en 2017

Deregulation of COMMD1 is associated with poor prognosis in diffuse large B-cell lymphoma

artículo científico publicado en 2014

Differential gene expression in non-malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP.

artículo científico publicado en 2006

Distinct subtypes of diffuse large B-cell lymphoma defined by hypermutated genes

artículo científico publicado en 2019

Drug screening approach combines epigenetic sensitization with immunochemotherapy in cancer

scientific article published on 11 December 2019

E6/E7 oncogenes increase and tumor suppressors decrease the proportion of self-renewing neural progenitor cells

artículo científico publicado en 2006

EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways.

artículo científico publicado en 2007

Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients.

artículo científico publicado en 2006

Effect of treatment of larynx and hypopharynx carcinomas on serum syndecan-1 concentrations

scientific article published on 24 March 2006

Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2.

artículo científico publicado en 2017

FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders

scientific article published on 28 October 2016

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma

artículo científico publicado en 2017

High serum vascular endothelial growth factor level is an adverse prognostic factor for high‐risk diffuse large B‐cell lymphoma patients treated with dose‐dense chemoimmunotherapy ⬇️

artículo científico publicado el 14 de septiembre de 2012

Hydrocortisone and indomethacin negatively modulate EGF-R signaling in human fetal intestine

artículo científico publicado en 2007

Identification of homozygous deletion inACANand other candidate variants in familial classical Hodgkin lymphoma by exome sequencing

artículo científico publicado en 2015

Identifying differentially methylated sites in samples with varying tumor purity

scientific article published on 01 September 2018

Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphoma.

artículo científico publicado en 2008

Intravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma

scientific article published on 10 May 2019

Late non-relapse mortality among adult autologous stem cell transplant recipients: a nation-wide analysis of 1482 patients transplanted in 1990–2003

artículo científico publicado en 2006

Low Absolute Lymphocyte Counts in the Peripheral Blood Predict Inferior Survival and Improve the International Prognostic Index in Testicular Diffuse Large B-Cell Lymphoma

artículo científico publicado en 2020

Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy.

artículo científico publicado en 2010

MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma.

artículo científico publicado en 2017

Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells

scientific article published on 01 February 2007

Mitogen-activated Protein Kinases and Activator Protein 1 Are Required for Proliferation and Cardiomyocyte Differentiation of P19 Embryonal Carcinoma Cells

artículo científico publicado en 2002

Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma

artículo científico publicado en 2022

Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study.

artículo científico publicado en 2016

PD-L1 tumor-associated macrophages and PD-1 tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma

scholarly article by Marjukka Pollari et al published November 2018 in Haematologica

Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma

artículo científico publicado en 2017

Pixantrone beyond monotherapy: a review

scientific article published on 17 July 2019

Primary mediastinal large B-cell lymphoma segregating in a family: exome sequencing identifies MLL as a candidate predisposition gene

artículo científico publicado en 2013

Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma

artículo científico publicado en 2020

Prognostic factors and treatment of diffuse large cell B-cell lymphoma

artículo científico publicado en 2014

Prognostic impact of CD31-positive microvessel density in follicular lymphoma patients treated with immunochemotherapy.

artículo científico publicado en 2010

Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial

artículo científico publicado en 2014

Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOP.

artículo científico publicado en 2008

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.

artículo científico publicado en 2019

Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma

artículo científico publicado en 2016

Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial.

artículo científico publicado en 2016

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

artículo científico publicado en 2010

Rituximab maintenance obviates the poor prognosis associated with circulating lymphoma cells in patients with follicular lymphoma

artículo científico publicado en 2014

Rituximab regulates signaling pathways and alters gene expression associated with cell death and survival in diffuse large B-cell lymphoma

artículo científico publicado en 2011

Signal transducers and activators of transcription 5a-dependent cross-talk between follicular lymphoma cells and tumor microenvironment characterizes a group of patients with improved outcome after R-CHOP.

artículo científico publicado en 2010

Similar outcomes in Asian and Western patients with diffuse large B-cell lymphoma treated with R-CHOP.

artículo científico publicado en 2013

Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group

artículo científico publicado en 2014

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study

artículo científico publicado en 2019

T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma

scholarly article by Suvi-Katri Leivonen et al published February 2019 in Haematologica

The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP.

artículo científico publicado en 2012

Total peroxiredoxin expression is associated with survival in patients with follicular lymphoma

artículo científico publicado en 2016

Transcription factor AP-1 promotes growth and radioresistance in prostate cancer cells

artículo científico publicado en 2009

Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study

artículo científico publicado en 2018

Lista de obras de Sirpa Leppä

(18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study.

A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.

Abstract 1169: Somatic MED12 mutations in hematological malignancies

Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells

Adverse prognostic impact of regulatory T-cells in testicular diffuse large B-cell lymphoma

Allogeneic Haematopoietic Stem Cell Transplantation for Patients with Cutaneous T-cell Lymphoma

Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma.

Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey.

Autologous stem cell transplantation in elderly (>60 years) patients with non-Hodgkin's lymphoma: a nation-wide analysis.

Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.

CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

Clinical features and outcome of the patients with sinonasal tract diffuse large B-cell lymphoma in the pre-rituximab and rituximab eras

Clinical findings in 25 patients with sinonasal or nasopharyngeal extramedullary plasmacytoma in a four-decade single-centre series

Clinical findings of extranodal SNT lymphoid malignancies in a four-decade single-centre series

Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma

Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study

Deltex-1 mutations predict poor survival in diffuse large B-cell lymphoma

Deregulation of COMMD1 is associated with poor prognosis in diffuse large B-cell lymphoma

Differential gene expression in non-malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP.

Distinct subtypes of diffuse large B-cell lymphoma defined by hypermutated genes

Drug screening approach combines epigenetic sensitization with immunochemotherapy in cancer

E6/E7 oncogenes increase and tumor suppressors decrease the proportion of self-renewing neural progenitor cells

EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways.

Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients.

Effect of treatment of larynx and hypopharynx carcinomas on serum syndecan-1 concentrations

Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2.

FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma

High serum vascular endothelial growth factor level is an adverse prognostic factor for high‐risk diffuse large B‐cell lymphoma patients treated with dose‐dense chemoimmunotherapy ⬇️

Hydrocortisone and indomethacin negatively modulate EGF-R signaling in human fetal intestine

Identification of homozygous deletion inACANand other candidate variants in familial classical Hodgkin lymphoma by exome sequencing

Identifying differentially methylated sites in samples with varying tumor purity

Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphoma.

Intravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma

Late non-relapse mortality among adult autologous stem cell transplant recipients: a nation-wide analysis of 1482 patients transplanted in 1990–2003

Low Absolute Lymphocyte Counts in the Peripheral Blood Predict Inferior Survival and Improve the International Prognostic Index in Testicular Diffuse Large B-Cell Lymphoma

Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy.

MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma.

Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells

Mitogen-activated Protein Kinases and Activator Protein 1 Are Required for Proliferation and Cardiomyocyte Differentiation of P19 Embryonal Carcinoma Cells

Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma

Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study.

PD-L1 tumor-associated macrophages and PD-1 tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma

Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma

Pixantrone beyond monotherapy: a review

Primary mediastinal large B-cell lymphoma segregating in a family: exome sequencing identifies MLL as a candidate predisposition gene

Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma

Prognostic factors and treatment of diffuse large cell B-cell lymphoma

Prognostic impact of CD31-positive microvessel density in follicular lymphoma patients treated with immunochemotherapy.

Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial

Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOP.

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma.

Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma

Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial.

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

Rituximab maintenance obviates the poor prognosis associated with circulating lymphoma cells in patients with follicular lymphoma

Rituximab regulates signaling pathways and alters gene expression associated with cell death and survival in diffuse large B-cell lymphoma

Signal transducers and activators of transcription 5a-dependent cross-talk between follicular lymphoma cells and tumor microenvironment characterizes a group of patients with improved outcome after R-CHOP.

Similar outcomes in Asian and Western patients with diffuse large B-cell lymphoma treated with R-CHOP.

Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study

T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma

The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP.

Total peroxiredoxin expression is associated with survival in patients with follicular lymphoma

Transcription factor AP-1 promotes growth and radioresistance in prostate cancer cells

Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study